BC HepTesters Cohort

The BC-HTC is a large cohort study of 1.7 million people tested for hepatitis C to monitor disease burden and impact of interventions on long-term outcomes.

[BC HepTesters Cohort @BCHepCo]

📢New paper on @VirusesMDPI 📢
#HBV infection 👉3⃣x⬆️risk of liver-related deaths VS not #HBV infected

VS those who have #HBV infection only, risk of liver-related deaths are:
1. 3⃣x⬆️👉#HBV & #HCV coinfection
2. 4⃣x⬆️👉#HBV & #NAFLD

Read more here: https://t.co/I9WydDr7Bl

[BC HepTesters Cohort @BCHepCo]

📢 Our team (@BCHepCo and @bc_a4ph) at @ubcspph and @CDCofBC is looking for a highly motivated postdoc to investigate #COVID19 and #HCV using large #HealthAdminData. Details and apply here: https://t.co/wSsAJRg8W8

#BigData #postdocjobs #hiringnow

[BC HepTesters Cohort @BCHepCo]

Treatment for #HBV is associated with lower deaths due to all causes and deaths that are #LiverRelated among people living with HBV who have cirrhosis in British Columbia. Learn more at the #CLM22 @CanLiverMeeting poster #P053 by @makuza_jean, available virtually

[BC HepTesters Cohort @BCHepCo]

Among people living with #HBV infection, those who also have non-alcoholic fatty liver disease #NAFLD or #HCV co-infection are at higher risk of #LiverRelated deaths. Catch @makuza_jean’s poster #P052 at the #CLM22 @CanLiverMeeting

[BC HepTesters Cohort @BCHepCo]

Catch the updated #HCV #carecascade for young people living with #HCV in British Columbia in 2020, poster presentation #P044 by @Dahn_Jeong @CanLiverMeeting, available virtual and in-person at #CLM22

[BC HepTesters Cohort @BCHepCo]

#Treat. #Cure. #Eliminate. Learn more about the impact of #COVID19 on #HCV treatment initiation in British Columbia in 2020 and 2021. Poster #P058 presented by @MawuenaBinka virtually and in-person at the #CLM22. @CanLiverMeeting

[BC HepTesters Cohort @BCHepCo]

We are presenting at the @CanLiverMeeting #CLM22! Check out our team's posters and oral presentation from our team’s Dr. @SofiaRB_88, Dr. @MawuenaBinka, Ms. @Dahn_Jeong, Dr. @makuza_jean and Dr.
@naveedjanjua!

[BC HepTesters Cohort @BCHepCo]

📢New #JobAlert !
The Opioid Prescribing Evaluation and Research Activities (OPERA) research team is searching for a new #epidemiologist to join their team. Think you are fit for the role? Apply now! https://t.co/MHiEkxl7yj

#HIRINGNOW #job #PrescriptionOpioid

[CATIE @CATIEinfo]

Curing hepatitis C associated with dramatic reduction in deaths from all causes. Read more: https://t.co/pjoUyCr7Fg #hepC #cdnhealth

[BC HepTesters Cohort @BCHepCo]

#DYK that #PeopleWhoUseDrugs #PWUD with chronic #HCV and are receiving #OpioidAgonistTherpay #OAT are more likely to start #DirectActingAntiviral #DAA treatment for #HCV compared those who are not receiving #OAT? Check out this paper by Dr. @SofiaRB_88: https://t.co/1Z4iZm1LcL

[BC HepTesters Cohort @BCHepCo]

#Diabetes is one of the extrahepatic manifestation #EHM of #HCV infection. #BCHTC data reveals: #HCV ⬆️ risk of diabetes & the risk was greater among East Asians and South Asians with #HCV compared to other ethnicities. Check out @Dahn_Jeong's paper here: https://t.co/AJsmXTaXV0

[BC HepTesters Cohort @BCHepCo]

#DYK Risk profiles of people diagnosed with #HBV, #HCV or #HIV (co)infections vary among ethnic groups? We need tailored screening approaches to diagnose and link visible ethnic minorities with care. Learn more about this paper by Dr. @mawuenabinka: https://t.co/hYFWS2kkac #NOHep

[BC HepTesters Cohort @BCHepCo]

Through analyzing the #BCHTC data, #DAA treatment was found to be associated with a substantial ⬇️ in deaths from all causes, liver disease, and drug-use. Learn more on this study from Dr. @NaveedJanjua here: https://t.co/BEjBXEIOaQ

[BC HepTesters Cohort @BCHepCo]

#DYK that public coverage for newer #DAA sofosbuvir and ledipasvir-sofosbuvir against #HCV has led to ⬆️ access to treatment and that there was high adherence rates to this treatment regimen? Read more on this study using #BCHTC data here: https://t.co/XuZMVKiDaM

[BC HepTesters Cohort @BCHepCo]

#DYK that compared to uninfected individuals, people living with #HCV, #HBV or #HIV infections or co-infections have a significantly ⬆️ risk of colorectal, pancreatic and liver cancers? Read more on this paper using #BCHTC data by Dr. @epi_darvishian here: https://t.co/rcGLQPVYPH

[BC HepTesters Cohort @BCHepCo]

Using #BCHTC data, the Opioid Prescribing Evaluation and Research Activities (OPERA) cohort was created to include individuals dispensed #PrescriptionOpioids for non-cancer pain in BC from 1996-2015. Read more on the cohort’s profile here: https://t.co/j5Debz0LPB

[BC HepTesters Cohort @BCHepCo]

#DYK that among #HCV positive #MenWhoHaveSexWithMen #MSM, there is a more than 2x ⬆️ chance of reinfection for those who spontaneously cleared the infection compared to those who were treated and achieved #SVR? Read more on this paper by Dr. @theprinceadu: https://t.co/3C8nwY80Qu

[BC HepTesters Cohort @BCHepCo]

#DYK that from 2008 to 2019, #HCV testing in pregnancy has ⬆️ significantly, but the proportion of women getting a new antibody HCV positive diagnosis as a result of a first HCV test during pregnancy ⬇️ 10x ? Read more on Dr. Margo Pearce’s paper here: https://t.co/xXLUF5CwHd

[BC HepTesters Cohort @BCHepCo]

From 2010-2018 in BC, although #drugrelateddeaths among people living with #HepC are much higher than among HCV-negative people, there has been a steep 📈 in the proportion of #drugrelateddeaths in both groups Read more on Dr. @HasinanisaH 's paper here: https://t.co/3tcKMXaklr

[BC HepTesters Cohort @BCHepCo]

Most health databases don’t have sexual orientation measures. Using the #BCHTC data, Dr. @travissalway and team developed and used a novel computable phenotyping approach in classifying #menwhohavesexwithmen #MSM. Read more on this topic here: https://t.co/rCWbCoLH7r